野生動物健康市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Wildlife Health Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月30日 | 出版商:

Global Market Insights Inc. | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球野生動物健康市場價值為23 億美元，預計2024 年至2032 年複合年成長率為8.9%。可以在動物和人類之間傳播。城市化、森林砍伐和氣候變遷加劇了人類與野生動物的互動，提高了全球對野生動物健康的認知。例如，2023 年 10 月，俄勒岡州立大學的研究人員根據美國農業部的一項協議，對約 1,600 份野生動物標本進行了 SARS-CoV-2 檢測，以確定可以隱藏和傳播該病毒的物種。該計劃強調了監測和管理野生動物健康以防止疾病傳播的重要性。政府機構和衛生機構正在投資野生動物健康舉措，增加了對獸醫服務、診斷工具和研究的需求。

整個野生動物健康產業根據物種、產品和服務、醫療器材、最終用戶和地區進行分類。

市場將物種分為哺乳動物、鳥類、魚類、爬蟲類和兩棲類。哺乳動物細分市場在 2023 年以 10 億美元的收入引領市場，預計將以 8.8% 的複合年成長率保持其主導地位。哺乳動物在生態系統和人畜共通傳染病傳播中發揮著至關重要的作用，這使得它們成為野生動物健康研究的核心。它們複雜的生理機能和多樣化的棲息地需要集中研究和監測，以管理和預防疾病爆發、保護生物多樣性並確保公眾健康。

市場將產品和服務分為藥品、醫療器材和獸醫服務。 2023年，藥品領域佔46.8%的市場佔有率，預計將繼續保持主導地位。該部分包括藥物、疫苗和醫療添加劑，對於管理和治療各種野生動物物種的疾病至關重要。對有效治療和預防措施的需求以及獸醫學的創新推動了市場的成長。此外，人們對人畜共通傳染病的認知不斷提高，以及野生動物保護工作中對強力的疾病管理的需求，進一步促進了製藥領域的擴張。

2023年，美國佔北美野生動物健康市場的9.213億美元，預計將大幅成長。美國憑藉其豐富的資源、先進的研究能力以及美國魚類和野生動物管理局和疾病預防控制中心等聯邦機構的大量投資而引領市場。該國還受益於致力於野生動物福利的強大獸醫機構網路。美國在監測、疾病管理和保育工作方面擁有強大的基礎設施，使其成為應對野生動物健康挑戰和推動市場發展的領導者。

產業生態系統分析
產業影響力
- 成長動力
  - 對人畜共通傳染病的擔憂日益增加
  - 野生動物保育意識和努力不斷提高
  - 診斷和野生動物健康福利的進步。
  - 政府和非政府組織對動物保健的支持不斷增加
  - 不斷增加的研究措施和資金
- 產業陷阱與挑戰
  - 嚴格的法規和複雜的法律框架
  - 治療和護理費用高
  - 缺乏野生動物獸醫
成長潛力分析
監管環境
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按物種，2021 - 2032 年

主要趨勢
哺乳動物
鳥類
魚
爬蟲類
兩棲類

第 6 章：市場估計與預測：按產品和服務分類，2021 - 2032 年

主要趨勢
藥品
- 藥品
- 疫苗
- 醫藥添加物
醫療器材
- 診斷設備
- 手術器械
- 監控設備
- 耗材
- 其他醫療器材
獸醫服務

第 7 章：市場估計與預測：按最終用戶分類，2021 - 2032 年

主要趨勢
野生動物復健中心
動物園和水族館
野生動物保護區
其他最終用戶

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Bimeda, Inc.
CJ Wildlife
Esaote SpA
Esco VacciXcell
Fagron
Hidrolab
Huvepharma
NexGen Pharmaceuticals
Nextech
Virbac
Telemetry solutions
Wildlife Computers

簡介目錄

Product Code: 11145

The Global Wildlife Health Market was valued at USD 2.3 billion in 2023 and is projected to grow at a CAGR of 8.9% from 2024 to 2032. This growth is driven by increased awareness of zoonotic diseases, which can spread between animals and humans. Urbanization, deforestation, and climate change have intensified human-wildlife interactions, raising global awareness of wildlife health. For instance, in October 2023, Oregon State University researchers, under a U.S. Department of Agriculture agreement, tested around 1,600 wild animal specimens for SARS-CoV-2 to identify species that can harbor and transmit the virus. This initiative highlights the importance of monitoring and managing wildlife health to prevent disease transmission. Government bodies and health agencies are investing in wildlife health initiatives, boosting demand for veterinary services, diagnostic tools, and research.

The overall wildlife health industry is classified based on the species, products and services, medical devices, end-user, and region.

The market categorizes species into mammals, birds, fish, reptiles, and amphibians. The mammals segment led the market in 2023 with USD 1 billion in revenue and is expected to maintain its dominance with a CAGR of 8.8%. Mammals play a crucial role in ecosystems and zoonotic disease transmission, making them central to wildlife health studies. Their complex physiology and diverse habitats necessitate focused research and monitoring to manage and prevent disease outbreaks, protect biodiversity, and ensure public health.

The market classifies products and services into pharmaceuticals, medical devices, and veterinary services. In 2023, the pharmaceuticals segment held a 46.8% market share and is expected to remain dominant. This segment includes drugs, vaccines, and medical additives, essential for managing and treating diseases across various wildlife species. The demand for effective treatments and preventive measures, along with innovations in veterinary medicine, drives the market's growth. Additionally, increasing awareness of zoonotic diseases and the need for robust disease management in wildlife conservation efforts further contribute to the expansion of the pharmaceuticals segment.

In 2023, the U.S. accounted for USD 921.3 million of the North American wildlife health market and is expected to grow significantly. The U.S. leads the market due to its extensive resources, advanced research capabilities, and substantial investments from federal agencies like the U.S. Fish and Wildlife Service and the CDC. The country also benefits from a robust network of veterinary institutions dedicated to wildlife welfare. The U.S.'s strong infrastructure for monitoring, disease management, and conservation efforts positions it as a leader in addressing wildlife health challenges and advancing the market.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing zoonotic disease concerns
  - 3.2.1.2 Rising awareness and efforts for wildlife conservation
  - 3.2.1.3 Advancements in diagnostics and wildlife health welfare.
  - 3.2.1.4 Rising government and NGO support for animal healthcare
  - 3.2.1.5 Growing research initiatives and funding
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Stringent regulations and complex legal frameworks
  - 3.2.2.2 High cost of treatment and care
  - 3.2.2.3 Lack of wildlife veterinarians
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Species, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Mammals
5.3 Birds
5.4 Fish
5.5 Reptiles
5.6 Amphibians

Chapter 6 Market Estimates and Forecast, By Products and Services, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Pharmaceuticals
- 6.2.1 Drugs
- 6.2.2 Vaccines
- 6.2.3 Medical additives
6.3 Medical devices
- 6.3.1 Diagnostic equipment
- 6.3.2 Surgical instruments
- 6.3.3 Monitoring devices
- 6.3.4 Consumables
- 6.3.5 Other medical devices
6.4 Veterinary services

Chapter 7 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Wildlife rehabilitation centers
7.3 Zoos and aquariums
7.4 Wildlife sanctuaries
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa